Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: G
Results 111 - 120 of 306 shown below
-
Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes
doi:10.1038/sj.bjc.6600190
-
Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer
doi:10.1054/bjoc.2001.1885
-
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity
doi:10.1038/sj.bjc.6601523
-
Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers
advance online publication, 2004-09-14 00:00:00.000;
doi:10.1038/sj.bjc.6602186
-
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
doi:10.1038/sj.bjc.6601645
-
Gene rearrangement and Chernobyl related thyroid cancers
doi:10.1054/bjoc.1999.0921
-
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
doi:10.1038/sj.bjc.6603556
-
Genetic regulation of MUC1 alternative splicing in human tissues
advance online publication, 2008-08-26 00:00:00.000;
doi:10.1038/sj.bjc.6604617
-
Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells
advance online publication, 2008-09-30 00:00:00.000;
doi:10.1038/sj.bjc.6604692
-
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
doi:10.1054/bjoc.2000.1415
-
Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease
advance online publication, 2009-04-21 00:00:00.000;
doi:10.1038/sj.bjc.6605045
-
Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma
doi:10.1054/bjoc.1999.0889
-
Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras
doi:10.1038/sj.bjc.6600089
-
Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: role of HIF-1
doi:10.1038/sj.bjc.6600576
-
Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1–5
doi:10.1038/sj.bjc.6600908
-
Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene
doi:10.1038/sj.bjc.6601064
-
Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells
doi:10.1038/sj.bjc.6601407
-
Forced expression of heat-shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth
doi:10.1038/sj.bjc.6601583
-
Targeting cytotoxic T lymphocytes for cancer immunotherapy
advance online publication, 2004-07-13 00:00:00.000;
doi:10.1038/sj.bjc.6602022
-
Impaired neutralising antibody formation and high transduction efficacy after isolated hepatic perfusion with adenoviral vectors
doi:10.1038/sj.bjc.6602151
-
Monitoring HSVtk suicide gene therapy: the role of [18F]FHPG membrane transport
doi:10.1038/sj.bjc.6602216
-
Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression
advance online publication, 2007-02-20 00:00:00.000;
doi:10.1038/sj.bjc.6603624
-
Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts
advance online publication, 2007-05-22 00:00:00.000;
doi:10.1038/sj.bjc.6603812
-
Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy
advance online publication, 2007-07-24 00:00:00.000;
doi:10.1038/sj.bjc.6603883
-
Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder
doi:10.1038/sj.bjc.6690124
-
Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
doi:10.1038/sj.bjc.6690217
-
Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo
doi:10.1038/sj.bjc.6690538
-
Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells
doi:10.1054/bjoc.2000.1346
-
Gene expression profiles in thyroid carcinomas
doi:10.1054/bjoc.2000.1483
-
Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
doi:10.1054/bjoc.2000.1734
-
Cancer gene therapy clinical trials: lessons for the future
doi:10.1054/bjoc.2001.2129
-
Activity (transcription) of the genes for MLH1, MSH2 and p53 in sporadic colorectal tumours with micro-satellite instability
advance online publication, 2004-04-20 00:00:00.000;
doi:10.1038/sj.bjc.6601823
-
Adenovirus-mediated interferon
gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic canceradvance online publication, 2005-08-02 00:00:00.000;
doi:10.1038/sj.bjc.6602713
-
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
doi:10.1038/sj.bjc.6690800
-
Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma
doi:10.1038/sj.bjc.6690818
